MALDI mass spectrometry BioMérieux Gets FDA 510(k) Clearance for MALDI-TOF Bacterial ID System The next-generation system, which received CE marking last year, identifies bacteria more rapidly and is now commercially available in the US. Agilent Q3 Revenues Up 6 Percent The firm's diagnostics and genomics group saw an 11 percent year-over-year revenue increase in the third quarter. Biodesix, MRM Proteomics Partner on Lung Cancer Assays Under the agreement, MRM Proteomics has granted Biodesix rights to use its iMALDI mass spectrometry technologies to develop blood-based tests for lung cancer. Bruker Receives FDA Approval for Expanded MALDI Biotyper The new version of the mass spectrometry-based system adds 144 microbial species to its database and includes new tools for sample preparation. At ASMS 2017, Vendors Focus on Software, Applications Premium With the exception of Thermo Fisher Scientific, which released three new instruments, vendors focused mainly on expanded applications of existing platforms. Feb 7, 2017 Bruker Daltonics, AMRI, HighRes Biosolutions Collaborate on Mass Spec for Drug Discovery Dec 2, 2016 TP53 Variants May Influence Cancer Risk in Taiwanese Lynch Syndrome Cohort May 11, 2016 Protea Tiptoes Towards Clinical Diagnostics With Mass Spec Imaging Melanoma Test Premium Apr 8, 2016 SimulTOF Looking to Apply its MALDI Instruments to Microbial ID Premium Feb 25, 2016 At MSACL 2016, Extra Attention on Mass Spec-Based Dx Nov 20, 2013 NCI Awards Labcyte $1M to Develop Mass Spec-based Cancer Biomarker Detection Method Aug 2, 2013 New Study Further Bolsters Case for Bruker's MALDI Biotyper as Broad Clinical Proteomics Platform Premium Jun 20, 2013 Bruker Signs Deal with ImaBiotech to Distribute Quantinetix Software for MALDI MS Imaging Jun 5, 2013 Bruker, CovalX Combine Technologies for MALDI MS-based Research Jun 4, 2013 Bruker Inks Patent License Deal with 3M for Technology Related to MALDI Imaging of FFPE Tissue May 14, 2013 Bruker Enters Partnership with Scils for MALDI Imaging Software Apr 29, 2013 BD, Bruker Update Collaboration on Antimicrobial Technologies Apr 19, 2013 Bruker, GBC Proteomics Centre Protein Assay Deal Points to New Clinical Markets for MALDI Biotyper Premium Apr 18, 2013 Bruker, Genome BC Proteomics Centre Team on Development of MALDI-MS Assays Apr 2, 2012 Bruker, UMCG Collaborating on Anaerobic Bacteria Identification Using MALDI Biotyper Dec 6, 2011 Ezose Sciences Integrated into Shionogi Diagnostic Business Nov 8, 2011 NCI Awards Labcyte $196K to Develop Cancer Biomarker Validation System Jul 22, 2011 Lung Cancer Study Highlights Current Limitations of MALDI Mass Spec Premium May 20, 2011 Yale Researcher Suggests More Focus on EGFR Isoforms Needed in Development of Antibody-Based Drugs Premium Apr 8, 2011 Vanderbilt Wins $10M from NCRR to Establish Proteomics Imaging Resource Premium Load More Breaking News Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis Evvy Closes $14M Series A for Vaginal Microbiome Testing, Launches Add-on STI Screen Consanguinity Contributes to Common Disease Risk, Study Suggests Ginkgo Bioworks, Pfizer Ink RNA Drug Discovery Deal Worth up to $331M The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.